Zynex, inc. (zyxi) shares under pressure amid tricare payment halt, dim outlook, and investor lawsuit – hagens berman

San francisco, april 09, 2025 (globe newswire) -- shares of zynex inc. (nasdaq: zyxi), a medical device manufacturer specializing in nerve stimulation products, are trading down 65% over the past month, as the company grapples with a confluence of financial setbacks, regulatory scrutiny, and a pending investor class action.
ZYXI Ratings Summary
ZYXI Quant Ranking